Physicians news and physicians widget
Friday, November 07, 2008 ( change date )
Efficacy, Dosage Concerns Unresolved on Sublingual Immunotherapy
Although sublingual immunotherapy (SLIT) is used in Europe and other countries, experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle say questions remain unanswered regarding its effectiveness, appropriate use, dosage, and safety of administration.
news-medical.net Friday, November 07, 2008FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
As part of the U.S. Food and Drug Administration's ongoing efforts to ensure that heparin for patients remains safe, the government today seized 11 lots of heparin from Celsus Laboratories Inc. in Cincinnati, Ohio.
news-medical.net Friday, November 07, 2008FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
CV Therapeutics, Inc. ( NASDAQ:CVTX ) announced today that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.
news-medical.net Friday, November 07, 2008Vitamin found in poultry, fish holds promise for Alzheimer's
Researchers report that huge doses of an ordinary vitamin appeared to eliminate memory problems in mice with the rodent equivalent ...
usatoday.com Friday, November 07, 2008MIT creates tiny backpacks for cells
MIT engineers have outfitted cells with tiny "backpacks" that could allow them to deliver chemotherapy agents, diagnose tumors or become building blocks for tissue engineering.
news-medical.net Friday, November 07, 2008Gene research sheds light on T-cell production
New research, just published by researchers from the University of Georgia, provides the first evidence that a key gene may be crucial to maintaining the production of the thymus and its disease-fighting T-cells after an animal's birth.
news-medical.net Friday, November 07, 2008Alteration of a gene causes neuroblastoma
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children-neuroblastoma. By studying the familial forms of this tumor, the researchers also conclude that ALK is a gene that predisposes to neuroblastoma.
news-medical.net Friday, November 07, 2008Report: Migraines might lower breast cancer risk
Women who experience migraines may actually have a 30% lower risk of developing breast cancer, say researchers from the Fred ...
usatoday.com Friday, November 07, 2008Officials: Kids shouldn't eat animals killed with lead bullets
North Dakota health officials are recommending that pregnant women and young children avoid eating meat from wild game killed ...
usatoday.com Friday, November 07, 2008Allegheny Bradford Corporation New Facility Construction Completed
Construction of our 50,000ft² new facility has now been completed. With the new facility, ABC can increase its capacity and expand its capabilities for tanks and large assemblies, which includes: CIP tanks, large tank skids, depth filter skids, WFI skids, bio-reactor vessel, tempering skids, fermenter vessels and bio-waste decontamination skids.
The new facility boasts 30ft under the hook and up to a capacity of 20t. It houses state-of-the-art manufacturing equipment and FAT utilities, including: oil free air, RO/DI water, clean steam, nitrogen and helium. There is also dedicated FAT ...
pharmaceutical-technology.com Friday, November 07, 20081 2 3 4 5

PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET